Titan Pharmaceuticals
TTNP
#10343
Rank
NZ$10.46 M
Marketcap
NZ$7.87
Share price
-3.76%
Change (1 day)
15.42%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.49. In 2023 the company made an earnings per share (EPS) of NZ-$12.64 an increase over its 2022 EPS that were of NZ-$25.92.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.64-51.22%
2022NZ-$25.92-15.61%
2021NZ-$30.72-81.37%
2020NZ-$164.84-77.52%
2019NZ-$733.41-56.32%
2018NZ-$1,679-59.51%
2017NZ-$4,147-371.81%
2016NZ$1,526-144.35%
2015NZ-$3,440300%
2014NZ-$860.03-121.54%
2013NZ$3,993-151.38%
2012NZ-$7,771-11.54%
2011NZ-$8,785188.89%
2010NZ-$3,041-10%
2009NZ-$3,379
2007NZ-$13,853-2.38%
2006NZ-$14,191-39.13%
2005NZ-$23,313-16.87%
2004NZ-$28,043-22.43%
2003NZ-$36,1524.9%
2002NZ-$34,46361.9%
2001NZ-$21,286-13.7%
2000NZ-$24,66565.01%
1999NZ-$14,948-35.87%
1998NZ-$23,309-1824.71%
1997NZ$1,351-102.4%
1996NZ-$56,424

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.00-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.56-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$2.42-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.05119-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.43-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.77-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA